X

Ranjit S. Dhindsa speaks at DRI seminar addressing the most pressing issues challenging aging services providers and medical professionals.

September 8, 2016-September 9, 2016

External registration form.

"Defending Litigation Related to Medications Used for Osteoporosis and Osteoarthritis" -- In his presentation, Mr. Dhindsa discussed risks to the facility and facility staff in situations where the drugs used to treat osteoporosis prevalent among the patients, who are at increased risk of falling and fracturing in the skilled nursing setting, are the subject of serial pharmaceutical product liability litigation. The discussion also included strategies to communicate these types of complex scientific issues to judges and juries when defending long term care facilities and practitioners.

What's
Hot

Bloomberg BNA: Monsanto: Cancer Study Suppression is ‘Scientific Vandalism’

Hollingsworth LLP represents Monsanto in In Re:Roundup Products Liability Litigation in the Northern District of California.